5066.0 Drug Policy & Pharmacy Services

Wednesday, October 29, 2008: 8:30 AM
The four conclusions of this session are as follows: 1.Disparities in depression treatment persist for African American elderly diagnosed with depression 2.Trained student pharmacists can provide community-based interventions resulting in cost savings to the underserved Medicare population 3.The approval rate of OD designations was correlated to the total number of OD designations made by a company 4.The safety labeling of drugs on the market is changed often. Panels of advisors only consider a few drugs, and rarely discuss the labeling requirements
Session Objectives: There are four objectives for this session. To: 1.Identify the populations that are at risk for undertreatment of depression 2.Recognize the potential of health professional students to provide cost-saving community interventions to vulnerable populations 3.Analyze the characteristics of the orphan drug designations and approvals approved by the FDA in the period 1983-2007 4.Describe the FDA process of risk management for prescription drugs

8:30 AM
Depression treatment among the U.S. elderly and the role of prescription drug coverage quality
Stephen Crystal, PhD, Ayse Akincigil, PhD and Michele Siegel, PhD
8:50 AM
Impact of student pharmacist interventions on Medicare Part D beneficiaries' out-of-pocket prescription drug plan costs
Amanda R. Smith, MPH, Helene Levens Lipton, PhD, Rajul Patel, PharmD, PhD, Timothy W. Cutler, PharmD and Marilyn R. Stebbins, PharmD
9:10 AM
9:30 AM
Risk Management Policy and FDA Black Box Warnings
Daniel Cook, PhD, Lisa Bero, PhD and Rama K. Gurugubelli, MBPS

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Medical Care
Endorsed by: Socialist Caucus

See more of: Medical Care